Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax(® )encapsulated CTL/T helper peptides

The incidence of cancer increases significantly in later life, yet few pre-clinical studies of cancer immunotherapy use mice of advanced age. A novel vaccine delivery platform (VacciMax(®),VM) is described that encapsulates antigens and adjuvants in multilamellar liposomes in a water-in-oil emulsion...

Descripción completa

Detalles Bibliográficos
Autores principales: Daftarian, Pirouz M, Mansour, Marc, Pohajdak, Bill, Fuentes-Ortega, Antar, Korets-Smith, Ella, MacDonald, Lisa, Weir, Genevieve, Brown, Robert G, Kast, W Martin
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904180/
https://www.ncbi.nlm.nih.gov/pubmed/17555571
http://dx.doi.org/10.1186/1479-5876-5-26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904180/
https://www.ncbi.nlm.nih.gov/pubmed/17555571
http://dx.doi.org/10.1186/1479-5876-5-26

Ejemplares similares